잠복결핵감염의 진단과 치료

키워드

참고문헌 (26)

1. 최창민, "The role of TST in the diagnosis of latent tuberculosis infection among military personnel in South Korea", INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 10(12), pp.1342~1346, INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
2. Lee JY, "Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection", Eur Respir J, 28, pp.24~30 (2006)
3. Joint Committee for the Development of Korean Guidelines for Tuberculosis, "Korean guidelines for tuberculosis", ~ (2011)
4. Shim T., "Diagnosis of latent tuberculosis infection", Medical review, 8, pp.31~35 (2011)
5. Shim T., "Treatment of latent tuberculosis infection", Medical review, 8, pp.22~25 (2011)
6. Mazurek GH, "Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection-United States, 2010", MMWR Recomm Rep, 59(RR-5), pp.1~25 (2010)
7. "Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control" (2006)[URL]
8. Wang L, "A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements", Thorax, 57, pp.804~809 (2002)
9. Canadian Tuberculosis Committee, "Recommendations on interferon gamma release assays for the diagnosis of latent tuberculosis infection-2010 update", CCDR Canada Communicable Disease Report, 36, pp.1~21 (2010)
10. Takahashi H, "Interferon gamma assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration", Rheumatol Int, 27, pp.1143~1148 (2007)
11. Vassilopoulos D, "Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment", J Rheumatol, 35, pp.1271~1276 (2008)
12. Chang B, "Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea", Clin Rheumatol, 30, pp.1535~1541 (2011)
13. Song S, "Performance of confirmatory interferon-gamma release assay in school tuberculosis outbreaks", Chest (2011)
14. "Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement", Am J Respir Crit Care Med, 161(4 Pt 2), pp.221~247 (2000)
15. Nolan CM, "Tuberculosis in a cohort of Southeast Asian Refugees: a five-year surveillance study", Am Rev Respir Dis, 137, pp.805~809 (1998)
16. Grzybowski S, "Tuberculosis among patients with various radiologic abnormalities, followed by the chest clinic service", Am Rev Respir Dis, 104, pp.605~608 (1971)
17. Comstock GW, "How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?", Int J Tuberc Lung Dis, 3, pp.847~850 (1999)
18. "A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong: Hong Kong Chest Service", Tuberculosis Research Centre, Madras, Am Rev Respir Dis, pp.1992, 145[DOI]
19. Polesky A, "Rifampin preventive therapy for tuberculosis in Boston's homeless", Am J Respir Crit Care Med, 154, pp.1473~1477 (1996)
20. Spyridis NP, "The effectiveness of a 9-month regimen of isoniazid alone versus 3-and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study", Clin Infect Dis, 45, pp.715~722 (2007)
21. Rennie TW, "Patient choice promotes adherence in preventive treatment for latent tuberculosis", Eur Respir J, 30, pp.728~735 (2007)
22. Centers for Disease Control and Prevention (CDC)., "Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection", MMWR Morb Mortal Wkly Rep, 60, pp.1650~1653 (2011)
23. Schechter M, "Weekly rifapentine", isoniazid or daily rifampin, Am J Respir Crit Care Med, pp.2006, 173[DOI]
24. Martinson NA, "New regimens to prevent tuberculosis in adults with HIV infection", N Engl J Med, 365, pp.11~20 (2011)
25. Sterling TR, "Three months of rifapentine and isoniazid for latent tuberculosis infection", N Engl J Med, 365, pp.2155~2166 (2011)
26. "Management of persons exposed to multidrug-resistant tuberculosis", MMWR Recomm Rep, 41(RR-11), pp.61~71 (1992)

관련 논문AI추천